Annual Retained Earnings
-$1.28 B
-$72.85 M-6.05%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual retained earnings is -$1.28 billion, with the most recent change of -$72.85 million (-6.05%) on December 31, 2023.
- During the last 3 years, ABUS annual retained earnings has fallen by -$230.69 million (-22.06%).
- ABUS annual retained earnings is now -6113.30% below its all-time high of -$20.55 million, reached on December 31, 1998.
Performance
ABUS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.33 B
-$19.72 M-1.50%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly retained earnings is -$1.33 billion, with the most recent change of -$19.72 million (-1.50%) on September 30, 2024.
- Over the past year, ABUS quarterly retained earnings has dropped by -$39.51 million (-3.05%).
- ABUS quarterly retained earnings is now -772.14% below its all-time high of -$152.96 million, reached on December 31, 2012.
Performance
ABUS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ABUS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | -3.0% |
| 3 y3 years | -22.1% | -10.8% |
| 5 y5 years | -58.5% | -10.8% |
ABUS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.6% | at low | -17.6% | at low |
| 5 y | 5-year | -31.6% | at low | -37.5% | at low |
| alltime | all time | -6113.3% | at low | -772.1% | at low |
Arbutus Biopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.33 B(+1.5%) |
| Jun 2024 | - | -$1.31 B(+1.5%) |
| Mar 2024 | - | -$1.29 B(+1.4%) |
| Dec 2023 | -$1.28 B(+6.1%) | -$1.28 B(+1.5%) |
| Sep 2023 | - | -$1.26 B(+1.6%) |
| Jun 2023 | - | -$1.24 B(+1.4%) |
| Mar 2023 | - | -$1.22 B(+1.4%) |
| Dec 2022 | -$1.20 B(+6.1%) | -$1.20 B(+1.9%) |
| Sep 2022 | - | -$1.18 B(+1.5%) |
| Jun 2022 | - | -$1.16 B(+1.2%) |
| Mar 2022 | - | -$1.15 B(+1.4%) |
| Dec 2021 | -$1.13 B(+8.5%) | -$1.13 B(+2.0%) |
| Sep 2021 | - | -$1.11 B(+2.2%) |
| Jun 2021 | - | -$1.09 B(+2.1%) |
| Mar 2021 | - | -$1.07 B(+1.9%) |
| Dec 2020 | -$1.05 B(+7.8%) | -$1.05 B(+2.0%) |
| Sep 2020 | - | -$1.03 B(+2.2%) |
| Jun 2020 | - | -$1.00 B(+1.7%) |
| Mar 2020 | - | -$986.93 M(+1.7%) |
| Dec 2019 | -$970.09 M(+20.5%) | -$970.09 M(+2.9%) |
| Sep 2019 | - | -$942.56 M(+9.9%) |
| Jun 2019 | - | -$857.26 M(+3.1%) |
| Mar 2019 | - | -$831.19 M(+3.2%) |
| Dec 2018 | -$805.22 M(+9.1%) | -$805.22 M(+2.7%) |
| Sep 2018 | - | -$784.33 M(+3.6%) |
| Jun 2018 | - | -$757.28 M(-0.1%) |
| Mar 2018 | - | -$757.84 M(+2.7%) |
| Dec 2017 | -$738.07 M(+13.1%) | -$738.07 M(+5.5%) |
| Sep 2017 | - | -$699.63 M(+1.7%) |
| Jun 2017 | - | -$688.03 M(+2.7%) |
| Mar 2017 | - | -$669.78 M(+2.6%) |
| Dec 2016 | -$652.75 M(+144.5%) | -$652.75 M(+50.9%) |
| Sep 2016 | - | -$432.45 M(+4.7%) |
| Jun 2016 | - | -$412.86 M(+46.0%) |
| Mar 2016 | - | -$282.86 M(+5.9%) |
| Dec 2015 | -$266.99 M(+29.7%) | -$266.99 M(+2.0%) |
| Sep 2015 | - | -$261.72 M(+12.5%) |
| Jun 2015 | - | -$232.74 M(+6.8%) |
| Mar 2015 | - | -$217.85 M(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -$205.86 M(+23.3%) | -$205.86 M(+3.1%) |
| Sep 2014 | - | -$199.70 M(+4.5%) |
| Jun 2014 | - | -$191.09 M(+3.3%) |
| Mar 2014 | - | -$185.01 M(+10.8%) |
| Dec 2013 | -$167.03 M(+9.2%) | -$167.03 M(-28.5%) |
| Sep 2013 | - | -$233.49 M(+4.6%) |
| Jun 2013 | - | -$223.14 M(-2.0%) |
| Mar 2013 | - | -$227.70 M(+48.9%) |
| Dec 2012 | -$152.96 M(-39.7%) | -$152.96 M(-43.7%) |
| Sep 2012 | - | -$271.64 M(+4.7%) |
| Jun 2012 | - | -$259.49 M(-1.2%) |
| Mar 2012 | - | -$262.61 M(+3.6%) |
| Dec 2011 | -$253.52 M(+1.9%) | -$253.52 M(+2.4%) |
| Sep 2011 | - | -$247.67 M(-6.1%) |
| Jun 2011 | - | -$263.85 M(+1.8%) |
| Mar 2011 | - | -$259.29 M(+4.2%) |
| Dec 2010 | -$248.87 M(+10.2%) | -$248.87 M(+10.1%) |
| Sep 2010 | - | -$225.98 M(+3.4%) |
| Jun 2010 | - | -$218.65 M(-1.5%) |
| Mar 2010 | - | -$221.96 M(-1.7%) |
| Dec 2009 | -$225.86 M(+29.6%) | -$225.86 M(+10.1%) |
| Sep 2009 | - | -$205.11 M(+10.0%) |
| Jun 2009 | - | -$186.41 M(+9.9%) |
| Mar 2009 | - | -$169.61 M(-2.7%) |
| Dec 2008 | -$174.27 M(-12.8%) | -$174.27 M(-11.8%) |
| Sep 2008 | - | -$197.55 M(-1.0%) |
| Jun 2008 | - | -$199.55 M(+3.6%) |
| Mar 2008 | - | -$192.62 M(-3.6%) |
| Dec 2007 | -$199.76 M(+19.2%) | -$199.76 M(+0.1%) |
| Sep 2007 | - | -$199.62 M(+6.4%) |
| Jun 2007 | - | -$187.59 M |
| Dec 2006 | -$167.53 M(-12.5%) | - |
| Dec 2005 | -$191.40 M(+8.1%) | - |
| Dec 2004 | -$177.12 M(+28.2%) | - |
| Dec 2003 | -$138.19 M(+56.0%) | - |
| Dec 2002 | -$88.61 M(+75.2%) | - |
| Dec 2001 | -$50.58 M(+32.5%) | - |
| Dec 2000 | -$38.18 M(+27.3%) | - |
| Dec 1999 | -$30.00 M(+46.0%) | - |
| Dec 1998 | -$20.55 M | - |
FAQ
- What is Arbutus Biopharma annual retained earnings?
- What is the all time high annual retained earnings for Arbutus Biopharma?
- What is Arbutus Biopharma annual retained earnings year-on-year change?
- What is Arbutus Biopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly retained earnings year-on-year change?
What is Arbutus Biopharma annual retained earnings?
The current annual retained earnings of ABUS is -$1.28 B
What is the all time high annual retained earnings for Arbutus Biopharma?
Arbutus Biopharma all-time high annual retained earnings is -$20.55 M
What is Arbutus Biopharma annual retained earnings year-on-year change?
Over the past year, ABUS annual retained earnings has changed by -$72.85 M (-6.05%)
What is Arbutus Biopharma quarterly retained earnings?
The current quarterly retained earnings of ABUS is -$1.33 B
What is the all time high quarterly retained earnings for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly retained earnings is -$152.96 M
What is Arbutus Biopharma quarterly retained earnings year-on-year change?
Over the past year, ABUS quarterly retained earnings has changed by -$39.51 M (-3.05%)